Per-account intelligence on the named CPG book — health, cash, whitespace and the next move for sales, key-account management and credit.
₹2,255 Cr of cross-sell whitespace sits across 12 accounts on ₹15,401 Cr of revenue, while 1 account book (₹3,121 Cr — the spread-driven converters & third-party chips trade) is flagged high-churn. Defend the price-sensitive commodity book first, then attach the value-added lines — Asepto, holography and specialty / PCR films — where the account expands fastest.
4 of 4 headline metrics improving vs prior · still off target: CPG Account Net Revenue Retention 104.0% vs 108.0%, Value-Added & Converting Revenue ₹5,069 Cr vs ₹6,200 Cr, Value-Added & Converting Mix 33.0% vs 40.0%
1 account book at high churn risk puts ₹3,121 Cr of revenue in play — the spread-driven chips & commodity-films trade churns on price when BOPET spreads move.
Each lost contract is value-added & converting revenue — the sticky book that carries the films cycle.
Each lost contract is value-added & converting revenue — the sticky book that carries the films cycle.
Each lost contract is value-added & converting revenue — the sticky book that carries the films cycle.
Pick an account — the company-cited CPG names (P&G, PepsiCo, Nestlé, Amul…) plus the overseas-films and chips books — for a one-page profile that turns the data into a move: a cross-sell play for sales (aseptic attach, holography, specialty films), an expansion/renewal plan for key-account management, and a collect-or-hold call for credit — each benchmarked against the portfolio.
Cross-sell into ₹640 Cr of account whitespace — Industrial, Pet-food & Others account already at 8% value-added; attach the missing line (Asepto aseptic packs, holography & security, or specialty / PCR films).
Repeat-order 102% is 4 below peer — build a business-review plan to grow the relationship before renewal.
Collections sprint — DSO 96d runs 17d over peer; clear the ₹610 Cr aged balance.
12 named accounts & books · ₹15,401 Cr revenue · ₹2,255 Cr of cross-sell whitespace · 1 at churn risk.
| Account | End-market | Revenue | Value-added | Repeat-order | DSO | Whitespace | Health | Verdict |
|---|---|---|---|---|---|---|---|---|
| Global CPGs — overseas films (150+ countries) | Industrial, Pet-food & Others | ₹6,180 Cr | ₹480 Cr | 102% | 96d | ₹640 Cr | 80 | Cross-sell |
| Converters & third-party chips | Third-party PET chips & films trade | ₹3,121 Cr | ₹119 Cr | 98% | 105d | ₹180 Cr | 68 | Defend |
| PepsiCo | Food & Snacks FMCG | ₹850 Cr | ₹620 Cr | 107% | 78d | ₹220 Cr | 90 | Cross-sell |
| P&G | Personal Care & Home | ₹780 Cr | ₹540 Cr | 106% | 80d | ₹190 Cr | 89 | Cross-sell |
| Nestlé | Food & Snacks FMCG | ₹760 Cr | ₹560 Cr | 108% | 76d | ₹200 Cr | 91 | Cross-sell |
| Coca-Cola | Beverages & Dairy (aseptic) | ₹700 Cr | ₹520 Cr | 109% | 74d | ₹160 Cr | 88 | Cross-sell |
| Amul | Beverages & Dairy (aseptic) | ₹620 Cr | ₹540 Cr | 111% | 62d | ₹150 Cr | 92 | Cross-sell |
| Mondelēz | Food & Snacks FMCG | ₹620 Cr | ₹420 Cr | 105% | 82d | ₹120 Cr | 84 | Cross-sell |
| Britannia | Food & Snacks FMCG | ₹540 Cr | ₹400 Cr | 106% | 70d | ₹110 Cr | 87 | Cross-sell |
| Tata Consumer | Beverages & Dairy (aseptic) | ₹480 Cr | ₹330 Cr | 107% | 72d | ₹95 Cr | 86 | Maintain |
| Haldiram's | Food & Snacks FMCG | ₹420 Cr | ₹300 Cr | 110% | 66d | ₹100 Cr | 88 | Cross-sell |
| L'Oréal | Personal Care & Home | ₹330 Cr | ₹240 Cr | 108% | 84d | ₹90 Cr | 83 | Grow |
Read it as a worklist: Cross-sell = whitespace ≥ ₹100 Cr · Grow = repeat-order ≥ 108% · Defend = high churn risk · everything else, maintain.
One click into the owning view — each reads the same live governed dataset.
The qualified attach list — aseptic, holography, specialty — ranked by value.
Work list →Resolve the golden record & term conflicts.
Resolve →Rack-and-stack accounts, brands or regions.
Compare →CEO brief — customer pulse and top actions.
Open →